Form 4: Regeneron EVP Exercises Options, Adjusts Holdings

Regeneron Pharmaceuticals' EVP, General Counsel, and Secretary, Joseph J. LaRosa, exercised stock options and subsequently disposed of shares for tax obligations.

Summary

• Joseph J. LaRosa, EVP General Counsel and Secretary of Regeneron Pharmaceuticals, Inc., exercised non-qualified stock options to acquire 14,450 shares of common stock at an exercise price of $555.67 per share on November 20, 2025.
• Concurrently, LaRosa disposed of 12,686 shares of common stock at a price of $736.77 per share on November 20, 2025, to cover tax liabilities associated with the option exercise.
• Following these transactions, LaRosa directly holds 22,839 shares of common stock.
• Indirect holdings include 9,000 shares via a 2024 GRAT, 9,000 shares via a 2025 GRAT, and 395 shares via a 401(k) Plan.
• The exercised stock option award, which vested in four equal annual installments, had an expiration date of December 16, 2025.

Sentiment

Score: 6

Explanation: The filing reports a routine executive stock option exercise and subsequent sale for tax purposes. While it shows an executive realizing value, it's a standard compensation event and does not indicate significant positive or negative sentiment about the company's immediate prospects beyond the executive's personal financial planning.

Positives

• The exercise of stock options indicates the executive is realizing value from vested compensation.
• The exercise price of $555.67 is significantly lower than the disposition price of $736.77, reflecting a substantial in-the-money gain for the executive.
• The executive retains a significant number of direct and indirect shares after the transactions, demonstrating continued equity interest in the company.

Negatives

• A substantial number of shares (12,686) were disposed of, reducing the executive's direct ownership, although this was primarily for tax withholding purposes.

Future Outlook

NA

Industry Context

NA

Key Dates

Keywords

Regeneron Pharmaceuticals, REGN, Joseph J. LaRosa, Insider Trading, Stock Option Exercise, Common Stock, SEC Form 4, Executive Compensation, Share Disposition, Tax Withholding